Oramed Pharmaceuticals Inc (ORMP)

9.33 +0.11  +1.19% NASDAQ Apr 22, 16:59 USD
View Full Chart
Price Chart
View All ORMP News

News

View All Events

Events

Date Type Description
07/07/2021 00:00 Earnings Results Q3 2021 Earnings Results
01/14/2021 00:00 Earnings Results Q1 2021 Earnings Results
08/03/2020 16:00 IST AGM 2019 Annual General Meeting
07/07/2020 00:00 Earnings Results Q3 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Oramed Pharmaceuticals Inc is a pharmaceutical company which is engaged in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The ORMD-0801 is a proprietary product which is an orally ingestible insulin capsule for the treatment of diabetes. Its other product includes Oral Glucagon-like peptide-1 which is an incretin hormone, a type of gastrointestinal hormone that stimulates the secretion of insulin from the pancreas.
  • URL: https://www.oramed.com
  • Investor Relations URL: https://www.oramed.com/investors/
  • HQ State/Province: New York
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: Jul. 07, 2021
  • Last Earnings Release: Jan. 14, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.